Quick access to main page (top) Direct access to main contents Quick access to main page (bottom)

First Recipient of Pig Kidney Transplant Passes Away: Mass. General Hospital Confirms

inews24 Views  

A man in his 60s who received a genetically modified pig kidney transplant in the U.S. last March has died two months following the procedure.

A photo of Richard Slayman, who received a genetically modified pig kidney transplant. [Photo=Massachusetts General Hospital Website]

According to an Associated Press (AP) report on the 11th (local time), Richard Slayman, a 62-year-old patient with end-stage kidney disease, received a pig kidney transplant at Massachusetts General Hospital (MGH) on March 16th.

The pig kidney, genetically modified by U.S. biotech company eGenesis, was the first case of its kind to be transplanted into a human. At the time, the medical team expected the pig kidney to function for at least two years, but the patient died about seven weeks after the transplant.

The MGH transplant team expressed their condolences for his death, stating there were no signs of Slayman dying from kidney transplant failure.

Slayman’s family thanked his doctors: “Their enormous efforts leading the xenotransplant gave our family seven more weeks with Rick, and our memories made during that time will remain in our minds and hearts.”

They also added that Slayman’s decision to undergo the transplantation was also meant to give hope to thousands who need a transplant to survive.

Meanwhile, over 100,000 people in the U.S. are on the organ transplant waiting list. Most of these are kidney disease patients, with thousands dying each year before their turn for transplantation comes.

inews24
content@viewusglobal.com

Comments0

300

Comments0

[WORLD] Latest Stories

  • China Targets U.S. Tech Industry with Rare Earth Export Freeze
  • Porsche Taycan GTS Breaks Guinness Record with 10.9-Mile Ice Drift
  • Africa's MPOX Variant Clade 1b Reaches France: Health Officials Take Action
  • LA Wildfires’ Economic Toll Hits $50 Billion, Doubling Early Estimates
  • Real Reason Trump Wants Greenland and the Panama Canal: Geopolitical Dominance
  • Biden Targets China, Russia with New Semiconductor Export Limits

You May Also Like

  • 1
    Bristol-Myers’ Schizophrenia Drug Falls Short in Key Trial

    LIFESTYLE 

  • 2
    Novavax COVID Vaccine Still on Hold—More Trials Needed, Says FDA

    LIFESTYLE 

  • 3
    Want to Lower Your Blood Pressure? Eat More Bananas, Study Says

    LIFESTYLE 

  • 4
    Weekend Workouts Are Enough to Cut Diabetes Risk, Study Says

    LIFESTYLE 

  • 5
    Brushing Right After Eating Could Hurt Your Teeth—Here’s Why

    LIFESTYLE 

Popular Now

  • 1
    Early Bedtimes Could Help Teens Boost Brain Power, Study Finds

    LIFESTYLE 

  • 2
    Scientists Find a New Reason to Snack on Walnuts

    LIFESTYLE 

  • 3
    It’s Not Just How Long You Sleep—It’s How You Sleep That Matters

    LIFESTYLE 

  • 4
    Want to Live to 100? Start Eating Like They Do in the Blue Zones

    LIFESTYLE 

  • 5
    Forget the Treadmill—This Machine Burns Twice the Calories in Half the Time

    LIFESTYLE 

Must-Reads

  • 1
    Bristol-Myers’ Schizophrenia Drug Falls Short in Key Trial

    LIFESTYLE 

  • 2
    Novavax COVID Vaccine Still on Hold—More Trials Needed, Says FDA

    LIFESTYLE 

  • 3
    Want to Lower Your Blood Pressure? Eat More Bananas, Study Says

    LIFESTYLE 

  • 4
    Weekend Workouts Are Enough to Cut Diabetes Risk, Study Says

    LIFESTYLE 

  • 5
    Brushing Right After Eating Could Hurt Your Teeth—Here’s Why

    LIFESTYLE 

Popular Now

  • 1
    Early Bedtimes Could Help Teens Boost Brain Power, Study Finds

    LIFESTYLE 

  • 2
    Scientists Find a New Reason to Snack on Walnuts

    LIFESTYLE 

  • 3
    It’s Not Just How Long You Sleep—It’s How You Sleep That Matters

    LIFESTYLE 

  • 4
    Want to Live to 100? Start Eating Like They Do in the Blue Zones

    LIFESTYLE 

  • 5
    Forget the Treadmill—This Machine Burns Twice the Calories in Half the Time

    LIFESTYLE 

Share it on...